| ASSET | YEAR | % RETURN |
|---|---|---|
Arena (AREN) | 2005 | -94.32% |
Travere Therapeutics (TVTX) | 2005 | -93.53% |
Abeona Therapeutics (ABEO) | 2005 | -85.56% |
Cogent Communications (CCOI) | 2005 | -75.05% |
Star Gas Partners (SGU) | 2005 | -75.03% |
Metalla Royalty & Streaming (MTA) | 2005 | -71.43% |
Rigel Pharmaceuticals (RIGL) | 2005 | -65.99% |
Innodata (INOD) | 2005 | -65.42% |
Axogen (AXGN) | 2005 | -65.22% |
Golden Entertainment (GDEN) | 2005 | -59.57% |
Beyond (BYON) | 2005 | -59.55% |
Neonode (NEON) | 2005 | -58.87% |
Skeena Resources (SKE) | 2005 | -57.89% |
Amarin (AMRN) | 2005 | -56.99% |
LifeMD (LFMD) | 2005 | -55.5% |
Newtek Business Services (NEWT) | 2005 | -55.43% |
OFG Bancorp (OFG) | 2005 | -54.77% |
Magic Software Enterprises (MGIC) | 2005 | -53.78% |
Lexicon Pharmaceuticals (LXRX) | 2005 | -53.5% |
Microvision (MVIS) | 2005 | -53.25% |
Americas Silver (USAS) | 2005 | -52.53% |
NeoGenomics (NEO) | 2005 | -52.5% |
Helen of Troy (HELE) | 2005 | -51.56% |
John B Sanfilippo & Son (JBSS) | 2005 | -49.49% |
Eyepoint Pharmaceuticals (EYPT) | 2005 | -48.57% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
